These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation. Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009 [TBL] [Abstract][Full Text] [Related]
11. Hepassocin activates the EGFR/ERK cascade and induces proliferation of L02 cells through the Src-dependent pathway. Gao M; Zhan YQ; Yu M; Ge CH; Li CY; Zhang JH; Wang XH; Ge ZQ; Yang XM Cell Signal; 2014 Oct; 26(10):2161-6. PubMed ID: 24768768 [TBL] [Abstract][Full Text] [Related]
12. Role of epidermal growth factor receptor transactivation in PPAR gamma-dependent suppression of Helicobacter pylori interference with gastric mucin synthesis. Slomiany BL; Slomiany A Inflammopharmacology; 2004; 12(2):177-88. PubMed ID: 15265318 [TBL] [Abstract][Full Text] [Related]
13. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells. Xu KP; Yin J; Yu FS Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2832-9. PubMed ID: 16799022 [TBL] [Abstract][Full Text] [Related]
14. Role of EGF Receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. Kodama H; Fukuda K; Takahashi T; Sano M; Kato T; Tahara S; Hakuno D; Sato T; Manabe T; Konishi F; Ogawa S J Mol Cell Cardiol; 2002 Feb; 34(2):139-50. PubMed ID: 11851354 [TBL] [Abstract][Full Text] [Related]
15. Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels. Chopra B; Georgopoulos NT; Nicholl A; Hinley J; Oleksiewicz MB; Southgate J Cell Prolif; 2009 Oct; 42(5):688-700. PubMed ID: 19614673 [TBL] [Abstract][Full Text] [Related]
16. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma. Li X; Yang X; Xu Y; Jiang X; Li X; Nan F; Tang H Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774 [TBL] [Abstract][Full Text] [Related]
17. Distinct calcium-dependent pathways of epidermal growth factor receptor transactivation and PYK2 tyrosine phosphorylation in PC12 cells. Zwick E; Wallasch C; Daub H; Ullrich A J Biol Chem; 1999 Jul; 274(30):20989-96. PubMed ID: 10409647 [TBL] [Abstract][Full Text] [Related]
18. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. Gao Y; Tang S; Zhou S; Ware JA J Pharmacol Exp Ther; 2001 Feb; 296(2):426-33. PubMed ID: 11160627 [TBL] [Abstract][Full Text] [Related]
19. Intracellular transactivation of epidermal growth factor receptor by α1A-adrenoceptor is mediated by phosphatidylinositol 3-kinase independently of activation of extracellular signal regulated kinases 1/2 and serine-threonine kinases in Chinese hamster ovary cells. Ulu N; Henning RH; Guner S; Zoto T; Duman-Dalkilic B; Duin M; Gurdal H J Pharmacol Exp Ther; 2013 Oct; 347(1):47-56. PubMed ID: 23902938 [TBL] [Abstract][Full Text] [Related]
20. Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca(2+) in opossum kidney cells. Kwon CH; Park JY; Kim TH; Woo JS; Kim YK Toxicology; 2009 Mar; 257(1-2):1-9. PubMed ID: 19110029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]